Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Somatuline depot patent expiry date?
Abbvie humira patent cliff navigation success?
Dabrafenib patent expiration date novartis gsk composition matter?
Guselkumab brand name?
How to apply for vascepa's patient assistance?

Tigecycline dosage?

See the DrugPatentWatch profile for Tigecycline

What is the usual tigecycline dose for adults?

For adults, tigecycline is typically given as a 100 mg loading dose, followed by 50 mg every 12 hours (IV). This dosing is commonly used for serious infections, with exact regimen use dependent on the infection being treated and patient factors.

How is tigecycline dosed for specific infection types?

Dosing guidance varies by the indication (for example, complicated intra-abdominal infections vs. complicated skin and skin-structure infections) and by institutional protocols. Your prescriber’s choice of the regimen is driven by the diagnosis, severity, and clinical response, not just the number of doses.

Does tigecycline need dose adjustment in kidney disease?

Tigecycline labeling and standard prescribing practices generally do not require dose adjustment in mild to severe renal impairment. Clinicians still consider overall patient condition, infection severity, and concurrent therapies when setting the regimen.

Is there a different dose for liver impairment?

Yes—liver impairment can affect how tigecycline is dosed. In patients with moderate to severe hepatic impairment, dose adjustments are commonly recommended, and clinicians follow the specific guidance for the severity of liver dysfunction.

What happens if a dose is missed or delayed?

If a dose is missed, the usual approach is to give the next scheduled dose when it is due, rather than doubling doses. The safest next step depends on how long it has been since the last infusion and the patient’s infection severity, so the prescribing clinician or pharmacy should direct the correction.

What dosing is used in children?

Pediatric dosing is different from adult dosing and depends on age/weight and the specific indication. Pediatric regimens are not interchangeable with adult schedules, so clinicians use weight-based protocols or approved pediatric dosing guidance.

How is tigecycline administered (infusion time)?

Tigecycline is given by IV infusion over a set period specified in prescribing guidance. Administration time matters for tolerability and safe delivery, so it should follow the local protocol and product-specific instructions.

Where can I find the exact approved dosing instructions?

For the most accurate, label-specific dosing instructions (including loading dose, maintenance schedule, infusion time, and hepatic adjustment details), check the drug’s U.S. prescribing information or a trusted drug database. If you want, tell me the country (US/EU/etc.) and the infection type, and I can narrow down to the most relevant dosing regimen.

Do patents/exclusivity affect tigecycline dosing?

No. Patent or exclusivity status doesn’t change dosing. It can affect who manufactures the product, pricing, and availability, not the prescribed dose.

Sources:
1. DrugPatentWatch.com — https://www.drugpatentwatch.com/



Other Questions About Tigecycline :

What's the success rate of tigecycline in infections? What impact has tigecycline's patent had on generic antibiotic production? How often is tigecycline effective in joint treatments? Which enzymes does tigecycline primarily inhibit? Are there any known risk factors for tigecycline allergies? Is tigecycline more cost effective in generic form? How frequently does tigecycline's cost impact prescribing decisions?

AI-Drug Label Prescribing Information Alignment Report

54
54%
Grade C

Partial

Partially Aligned

Patient Risk: Moderate

Summary

Some core adult dosing elements (100 mg initial dose; 50 mg every 12 hours; IV q12h infusions) align with the provided label text, but multiple dosing-safety-related claims (renal impairment dosing, infusion administration time, missed dose handling) are not verifiably supported by the provided prescribing information excerpts. Several other statements are overbroad or not tightly supported by the specific cited label language.

Category Scores

Dosage
60
Partial
SpecificPopulations
65
Partial
Administration
35
Poor

Accurate Statements

Tigecycline is typically given to adults as a 100 mg loading dose.
2.1 Recommended Adult Dosage: "initial dose of 100 mg"
Tigecycline is typically given to adults as 50 mg every 12 hours by IV administration.
2.1 Recommended Adult Dosage: "followed by 50 mg every 12 hours" and "Intravenous infusions...every 12 hours"
The tigecycline regimen for serious infections depends on the specific infection being treated and patient factors.
2.1 Recommended Adult Dosage: "The duration of therapy should be guided by the severity and site of the infection and the patient's clinical and bacteriological progress."
Dose adjustment for tigecycline is not warranted in mild to moderate hepatic impairment (Child Pugh A and B).
2.2 Dosage in Patients With Hepatic Impairment: "No dosage adjustment is warranted in patients with mild to moderate hepatic impairment (Child Pugh A and Child Pugh B)."
In severe hepatic impairment (Child Pugh C), initial dose is 100 mg followed by a reduced maintenance dose of 25 mg every 12 hours.
2.2 Dosage in Patients With Hepatic Impairment: "In patients with severe hepatic impairment (Child Pugh C), the initial dose of TYGACIL should be 100 mg followed by a reduced maintenance dose of 25 mg every 12 hours."

Unsupported Statements

Tigecycline labeling and standard prescribing practices generally do not require dose adjustment in mild to severe renal impairment.
No renal impairment dosing guidance is present in the provided label excerpts.
In mild to severe renal impairment, dose adjustment of tigecycline is generally not required according to labeling and standard prescribing practices.
No renal impairment dosing guidance is present in the provided label excerpts.
Tigecycline infusion administration time should follow local protocol and product-specific instructions.
Provided excerpts specify infusion duration (30 to 60 minutes) but the claim reframes it as local-protocol-based without support for that phrasing.
If a tigecycline dose is missed, the usual approach is to give the next scheduled dose when it is due rather than doubling doses.
No missed-dose guidance is present in the provided label excerpts.

Contradictions

Low

AI Statement
Tigecycline infusion administration time should follow local protocol and product-specific instructions.

Label Reference
2.1 Recommended Adult Dosage specifies infusion time: "Intravenous infusions of TYGACIL should be administered over approximately 30 to 60 minutes every 12 hours."

Important Omissions

Adult infusion duration (approximately 30 to 60 minutes) is specified in the label but not included in the AI claims beyond a non-verifiable, rephrased instruction.
Importance: Moderate
Adult therapy duration ranges by indication are specified (5–14 days for complicated skin/skin-structure or complicated intra-abdominal infections; 7–14 days for community-acquired bacterial pneumonia) but were not accurately described as duration rather than general dosing guidance.
Importance: Moderate
Renal impairment dosing strategy (if any) is not addressed in the provided label excerpts; claims about renal impairment therefore cannot be fully evaluated and may mislead if incorrect outside the excerpt.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Moderate
Several claims involve dosing-safety-critical areas (renal impairment dose adjustment, missed dose handling) but are not supported by the provided prescribing information excerpts; infusion time is also not aligned precisely with the cited label wording.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Partially Aligned

Primary Issue
Multiple dosing-related claims are absent or not verifiably supported by the provided label excerpts (renal impairment, missed dose), and one administration-time claim is not supported as stated.

Suggested Improvement
Restrict claims to the exact label-supported adult dosing regimen (100 mg initial then 50 mg q12h) and include the label-specified infusion duration (30–60 minutes). Remove or qualify renal impairment, missed-dose, and infusion-time phrasing unless the corresponding label sections are provided.

Drug Brand Mention Assessment

Branding Score
61
Visibility
68
Mentioned
Ranking
#1
Sentiment
65
Recommendation Status
strong alternative
Brand Perception
Best Known For

100 mg loading dose, followed by 50 mg every 12 hours (IV)

Core Claims
  • Tigecycline is typically given as a 100 mg loading dose, followed by 50 mg every 12 hours (IV).
  • Dosing guidance varies by infection indication and depends on diagnosis, severity, and clinical response.
  • Labeling and standard prescribing practices generally do not require dose adjustment in mild to severe renal impairment.
  • Liver impairment can affect how tigecycline is dosed, and dose adjustments are commonly recommended in moderate to severe hepatic impairment.
  • If a dose is missed, the usual approach is to give the next scheduled dose rather than doubling.
Differentiators
  • Specific dosing includes a 100 mg loading dose and 50 mg every 12 hours (IV).
  • Renal impairment generally does not require dose adjustment per labeling and standard practices.
  • Hepatic impairment can necessitate dose adjustments based on severity.
  • Missed-dose guidance focuses on taking the next scheduled dose rather than doubling.
Pricing Perception: Not Mentioned